http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1348088-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56ee5285e8e8edccb061046ff20da7a6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 1972-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1974-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1348088-A
titleOfInvention Nitrofuran and nitrothiophene derivatives
abstract 1348088 Nitrofuran and nitrothiophene derivatives BOEHRINGER MANNHEIM GmbH 24 Oct 1972 [29 Oct 1971] 48937/72 Addition to 1318013 Heading C2C Novel compounds of Formula I (in which X is S or O, Het is atriazolopyridazine or thiadiazole system and R is an acylamino, acylaminoalkylamino, carbalkoxyalkylamino or cycloalkylamino radical or a piperidino or 1- piperazinyl radical substituted in the 4-position by a hydroxyl or hydroxyalkyl group) and pharmacologically acceptable acid addition salts thereof, are prepared by (a) reacting a compound of Formula II (in which R 1 is C 1-6 alkyl) or a salt thereof with a compound of Formula HR, or (b) condensing a compound of Formula III with a compound Z=CH-R (in which Z is O or S) or with a reactive derivative thereof, or (c) nitrating a compound of Formula IV and, if desired, converting a compound I obtained into a pharmalogically acceptable acid addition salt. The compounds I in which R is acylamino or cycloalkylamino can also be prepared by reacting a compound I in which R is NH 2 with an acylating or cycloalkylating agent. Starting materials of Formula II are prepared by reacting a compound III with appropriate ortho esters, or by reacting corresponding N- (C 1-6 acyl) derivatives of compounds III with trialkoxonium fluoborates. 3 - (5 - Nitro - 2 - furyl) - 5 - amino - 1,2,4- thiadiazole is prepared by reacting 5-nitro-2- furamidine hydrochloride with trichloromethylsulphenyl chloride to give 3-(5-nitro-2-furyl)-5- chloro-1,2,4-thiadiazole and reacting this with ammonia. 3 - (5 - Nitro - 2 - -furyl) - 6 - (aminomethyleneamino) - s - triazolo[4,3-b] - pyridazine is prepared by reacting 3-(5-nitro-2-furyl)-6-ethoxymethyleneamino - s - triazolo[4,3-b] - pyridazine with ammonia. 3 - (5 - Nitro - 2 - thienyl) - 6 - amino - striazolo[4,3-b]-pyridazine is prepared by reacting 5 - nitrothiophene - 2 - aldehyde with 3- hydrazino - 6 - chloropyridazine to give the corresponding hydrazone, cyclizing this to give 3 - (5 - nitro - 2 - thienyl) - 6 - chloro - s - triazolo- [4,3-b]pyridazine and aminating this by treating with potassium phthalimide followed by acidic fission to give the desired compound. Pharmaceutical compositions having antimicrobial activity, for oral or parenteral administration, comprise a compound I, or a pharmalogically acceptable acid addition salt thereof, together with a pharmaceutical carrier.
priorityDate 1971-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421848704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414868950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21537451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID100787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21422385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421848737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21537420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415805857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3356745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409771379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135889290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21537490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421848718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421848703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449018643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421848768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409298605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21537501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426285827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21537573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408714604

Total number of triples: 50.